XML 18 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Feb. 03, 2018
Jan. 28, 2017
Jan. 30, 2016
Cash flows from operating activities:      
Net income $ 390,498 $ 378,159 $ 362,912
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 118,912 115,801 114,756
Share-based compensation 24,264 16,506 15,064
Debt issuance costs amortization 5,098 6,583 8,467
Accretion of long-term debt, net (505) (334) (150)
Deferred income taxes 4,348 4,570 8,611
Losses on early extinguishments of debt and refinancing costs   7,292 8,485
Losses (gains) on disposition of property and equipment   120 (25)
Excess tax benefits from share-based compensation   (10,027) (14,507)
Changes in assets and liabilities, excluding acquired net assets:      
Merchandise inventories 5,281 (40,800) (44,213)
Prepaid expenses and other (7,785) (1,004) (4,875)
Accounts receivable (2,992) 8,948 3,725
Other assets (1,765) (711) (34)
Accounts payable (38,025) 38,248 24,217
Accrued interest (12,040) 7,015 1,852
Accrued liabilities and other 3,174 (4,806) (23,530)
Income taxes 28,388 37,276 44,941
Other liabilities 6,759 1,581 (1,649)
Net cash provided by operating activities 523,610 564,417 504,047
Cash flows from investing activities:      
Additions to property and equipment (127,830) (114,462) (123,920)
Acquisition of Lamrite West, net of cash acquired   (151,100)  
Purchases of long-term investments   1,325 5,000
Net cash used in investing activities (127,830) (266,887) (128,920)
Cash flows from financing activities:      
Common stock repurchased (253,752) (404,971) (21,977)
Payment of PIK notes     (184,467)
Payments on term loan credit facility (31,125) (18,675) (174,900)
Borrowings on asset-based revolving credit facility 382,200 42,000 45,047
Payments on asset-based revolving credit facility (382,200) (42,000) (45,047)
Payment of debt issuance costs   (11,326)  
Payment of dividends (408) (415) (492)
Proceeds from stock options exercised 16,588 17,252 22,655
Excess tax benefits from share-based compensation   10,027 14,507
Other financing activities     643
Net cash used in financing activities (268,697) (408,108) (344,031)
Net change in cash and equivalents 127,083 (110,578) 31,096
Cash and equivalents at beginning of period 298,813 409,391 378,295
Cash and equivalents at end of period $ 425,896 $ 298,813 $ 409,391